Product/Service

Manufacturing At Scale

quality control, sterile pharmaceutical manufacturing facility-GettyImages-2277115553

A multi-site manufacturing network supporting vaccines, biologics and specialty injectables—with significant infrastructure expansion planned through 2029.

The Architecture of Biological Excellence.

Facilities across Shameerpet, Gaganpahad and Azamabad support development, manufacturing and global supply programs.

Infrastructure Includes

  • Drug Substance Manufacturing
  • Drug Product Manufacturing
  • Fill-Finish Operations
  • Packaging
  • Storage Capabilities

Filling Infrastructure

12 Filling Lines Across 2 Manufacturing Sites

Providing flexibility across clinical and commercial manufacturing programs.

Expansion Roadmap

Manufacturing Capabilities

Drug substance manufacturing, drug product manufacturing, fill-finish operations, packaging and storage capabilities supporting the full product lifecycle.

Expansion Roadmap 2027

  • Monoclonal Antibody Development Laboratories
  • ADC Development Laboratories
  • GMP Pilot Manufacturing Facilities

2029

  • Commercial Monoclonal Antibody Manufacturing Facility
  • Greenfield Drug Product Manufacturing Facility

Integrated R&D & Pilot Plant Capabilities

Accelerating Development Through Integrated Expertise

Biosol's integrated development and pilot-scale infrastructure is designed to accelerate timelines, reduce risk and support efficient scale-up.

Biosol Integrated Platform

Process Development

Upstream and downstream process optimization supporting manufacturing readiness.

Analytical Development

Comprehensive analytical capabilities supporting characterization, method development and regulatory readiness.

Device Development

Capabilities supporting advanced delivery systems and drug-device combination products.

Technology Transfer

Structured programs supporting efficient progression into manufacturing.

Pilot Manufacturing

Infrastructure supporting process validation, technology transfer and GMP clinical manufacturing.

Pilot Manufacturing

Infrastructure supporting process validation, technology transfer and GMP clinical manufacturing.

Ready to Explore Our Facilities & Capabilities?

DOur team can guide you through our current manufacturing infrastructure, technical capabilities, and future expansion plans to support your program requirements.